BioCentury | May 6, 2013
Company News

Haemonetics, Hemerus Medical deal

...royalties on SOLX-based products with maximum royalties of $14 million. Haemonetics Corp. (NYSE:HAE), Braintree, Mass. Hemerus Medical LLC...
BioCentury | May 7, 2012
Company News

Haemonetics, Hemerus Medical, Pall deal

...to close in Haemonetics' second fiscal quarter ending Sept. 30. Haemonetics Corp. (NYSE:HAE), Braintree, Mass. Hemerus Medical LLC...
BioCentury | Feb 2, 2004
Company News

Hemerus Medical LLC, Techne deal

...a joint venture with Hemerus to research filter technology applications for use in laboratory environments. Hemerus Medical LLC...
BioCentury | Jan 27, 2004
Financial News

Techne beats Street

...increased 15% to $38.3 million. TECH also disclosed that it purchased a 10% interest in Hemerus Medical...
Items per page:
1 - 4 of 4
BioCentury | May 6, 2013
Company News

Haemonetics, Hemerus Medical deal

...royalties on SOLX-based products with maximum royalties of $14 million. Haemonetics Corp. (NYSE:HAE), Braintree, Mass. Hemerus Medical LLC...
BioCentury | May 7, 2012
Company News

Haemonetics, Hemerus Medical, Pall deal

...to close in Haemonetics' second fiscal quarter ending Sept. 30. Haemonetics Corp. (NYSE:HAE), Braintree, Mass. Hemerus Medical LLC...
BioCentury | Feb 2, 2004
Company News

Hemerus Medical LLC, Techne deal

...a joint venture with Hemerus to research filter technology applications for use in laboratory environments. Hemerus Medical LLC...
BioCentury | Jan 27, 2004
Financial News

Techne beats Street

...increased 15% to $38.3 million. TECH also disclosed that it purchased a 10% interest in Hemerus Medical...
Items per page:
1 - 4 of 4